TrialPloS one2025

Measles neutralising antibody levels in patients receiving intravenous immunoglobulin treatment - a sub-analysis of a randomized, cross-over bioequivalence trial.

Vatsala Rajendram et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.